During the past decade, San Diego Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "San Diego Cancer Center" #1 sponsor was "Cephalon" with 2 trials, followed by "Translational Oncology Research International" with 2 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored, "Cell Genesys" with 1 trials sponsored and "Chiron Corporation" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "San Diego Cancer Center" #1 collaborator was "Bayer" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Aventis Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "San Diego Cancer Center" are "Prostate Cancer" (3 trials), "Colonic Neoplasms" (2 trials), "Colorectal Neoplasms" (2 trials), "Non-Hodgkin's Lymphoma" (2 trials) and "Rectal Neoplasms" (2 trials). Many other conditions were trialed in "San Diego Cancer Center" in a lesser frequency.

Most popular intervention types in "San Diego Cancer Center" are "Drug" (10 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Vatalanib" (2 trials), "Bevacizumab (drug), Herceptin (drug)" (1 trials), "Chemotherapy (Taxotere and prednisone)" (1 trials), "Erlotinib + Bevacizumab" (1 trials) and "Immunotherapy with allogeneic prostate vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "San Diego Cancer Center" are 6 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "San Diego Cancer Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in San Diego Cancer Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in San Diego Cancer Center, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".